Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - rocuronium bromide, quantity: 50 mg - injection, solution - excipient ingredients: sodium hydroxide; acetic acid; water for injections; sodium acetate trihydrate; sodium chloride - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - rocuronium bromide, quantity: 100 mg - injection, solution - excipient ingredients: glacial acetic acid; water for injections; sodium acetate trihydrate; sodium chloride - rocuronium bromide injection is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Kenya - English - Pharmacy and Poisons Board

rotexmedica gmbh arzneimittelwerk bunsenstrasse 4, 22946 trittau, germany - pancuronium bromide - solution for injection - 1 ampoule of 2 ml contains 4 mg pancuronium… - peripherally acting muscle relaxants:

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pancuronium bromide, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium acetate; sodium chloride; acetic acid; sodium hydroxide - indiactions as at 1 january 1991: 1. as an adjunct to surgical anaesthesia to induce skeletal muscle relaxation to facilitate operative manipulations. the necessary conditions for intubation can be achieved with pancuronium bromide alone or following suxamethonium. 2. pancuronium bromide is also indicated to promote mechanical ventilation by reducing or eliminating spontaneous breathing effort in intensive care patients.

Canada - English - Health Canada

sandoz canada incorporated - pancuronium bromide - solution - 2mg - pancuronium bromide 2mg - neuromuscular blocking agents

Canada - English - Health Canada

sandoz canada incorporated - pancuronium bromide - solution - 1mg - pancuronium bromide 1mg - neuromuscular blocking agents

Malta - English - Medicines Authority

inresa arzneimittel gmbh obere hardtstrasse 18, 79114 freiburg, germany - pancuronium bromide - solution for injection - pancuronium bromide 2 mg/ml - muscle relaxants

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pancuronium bromide - solution for injection - pancuronium bromide 4 mg - muscle relaxants

Namibia - English - Namibia Medicines Regulatory Council

pharmaplan (pty) ltd - pancuronium bromide - injection - pancuronium bromide injection 2mg/ml (single dose)

United States - English - NLM (National Library of Medicine)

the medicines company - rocuronium bromide (unii: i65mw4ofhz) (rocuronium - unii:wre554rfez) - rocuronium bromide 10 mg in 1 ml - rocuronium bromide injection is indicated for inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. rocuronium bromide is contraindicated in patients known to have hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents [ see warnings and precautions (5.2) ]. pregnancy category c: developmental toxicology studies have been performed with rocuronium bromide in pregnant, conscious, nonventilated rabbits and rats.  inhibition of neuromuscular function was the endpoint for high dose selection.  the maximum tolerated dose served as the high dose and was administered intravenously 3 times a day to rats (0.3 mg/kg, 15% to 30% of human intubation dose of 0.6 to 1.2 mg/kg based on the body surface unit of mg/m 2 ) from day 6 to 17 and to rabbits (0.02 mg/kg, 25% human dose) fr